Biological and clinical implications of the MTHFR C677T polymorphism
Top Cited Papers
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 22 (4) , 195-201
- https://doi.org/10.1016/s0165-6147(00)01675-8
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with IBD ReplyGut, 2000
- Hyperhomocysteinemia in hemodialysis patients: Effects of 12-month supplementation with hydrosoluble vitaminsKidney International, 2000
- 677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsiaPublished by Wolters Kluwer Health ,2000
- Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 1999
- Maternal Vitamin Use, Genetic Variation of Infant Methylenetetrahydrofolate Reducatase, and Risk for spina BifidaAmerican Journal of Epidemiology, 1998
- Homocysteine and Cardiovascular DiseaseAnnual Review of Medicine, 1998
- Neural Tube and Craniofacial Defects With Special Emphasis On Folate Pathway GenesCritical Reviews in Oral Biology & Medicine, 1998
- The effect of l-dopa administration and folate deficiency on plasma homocysteine concentrations in ratsThe Journal of Nutritional Biochemistry, 1997
- Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.Journal of Clinical Investigation, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995